BRCA1 and metastasis: Notably, BRCA1 mutation carriers and BRCA1/2 mutation carriers were significantly more likely to be positive in lymph node metastasis, when compared with non‐BRCA mutation carriers (p = 0.025 and 0.024, respectively).